A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly indicated for the administration to patients once or twice a day and it can be used also for pediatric administration.

Prolonged release pharmaceutical composition comprising cysteamine or salt thereof / A. Gazzaniga, M. Cerea, A. Maroni, M. Barchielli.

Prolonged release pharmaceutical composition comprising cysteamine or salt thereof

A. Gazzaniga;M. Cerea;A. Maroni;
2021

Abstract

A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly indicated for the administration to patients once or twice a day and it can be used also for pediatric administration.
Recordati Industria chimica e farmaceutica S.P.A
US11135173B2
US201716084308A
EP2017055964W
5-ott-2021
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
Prolonged release pharmaceutical composition comprising cysteamine or salt thereof / A. Gazzaniga, M. Cerea, A. Maroni, M. Barchielli.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/625488
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact